FDA Escalates Engagement With LASIK Providers In Letters To Medical Societies
This article was originally published in The Gray Sheet
In addition to building pressure on the LASIK device field, recent letters to eye surgery and ophthalmology societies raise questions about FDA’s authority over physician activities.
You may also be interested in...
FDA begins releasing summary review memos for 180-day PMA supplements as part of a transparency pilot. Invacare and FDA agree on consent decree terms. More regulatory news.
Billboards and advertising inserts promoted the Lap-Band procedure without providing adequate risk information, FDA charges.
FDA is on the lookout for physicians who promote medical devices for unapproved uses, as well as the companies that contract with them, regulators said last week at a Food and Drug Law Institute meeting